Chronic infantile neurological cutaneous articular syndrome

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
Status:
Terminated
Last Changed:
Dec 1, 2016
First Changed:
Sep 23, 2003
Disease(s):
Nervous System Malformations
Intervention(s):
anakinra
Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease
Status:
Terminated
Last Changed:
May 4, 2012
First Changed:
Oct 10, 2008
Disease(s):
NOMID
Intervention(s):
Canakinumab

Connect. Empower. Inspire.